THC Therapeutics, Inc. (THCT)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 1393.00 12.33 Thousand 16.37 Thousand 20.11 Thousand 25.55 Thousand 25.43 Thousand
Gross Profit -1393.00 -12.33 Thousand -16.37 Thousand -20.11 Thousand -25.55 Thousand -25.43 Thousand
Operating Expenses 493.91 Thousand 1.74 Million 939.97 Thousand 1.31 Million 24.25 Million 769.91 Thousand
Selling, General and Administrative Expenses 493.91 Thousand 1.74 Million 939.97 Thousand 1.29 Million 24.23 Million 744.48 Thousand
Research and Development Expenses - - - - - -
Other Expenses - 1.42 Million 473.14 Thousand 20.11 Thousand 25.55 Thousand 25.43 Thousand
Cost and Expenses 493.91 Thousand 1.74 Million 939.97 Thousand 1.31 Million 24.25 Million 769.91 Thousand
Operating Income -493.91 Thousand -1.74 Million -939.97 Thousand -1.31 Million -26.68 Million -5.99 Million
Interest Expense 79.57 Thousand 100.4 Thousand 551.75 Thousand 487.7 Thousand 303.58 Thousand 101.69 Thousand
Income Tax Expense - -227.09 Thousand 551.75 Thousand 487.7 Thousand 303.58 Thousand 147.48 Thousand
Earnings before Tax -387.03 Thousand -1.51 Million -1.88 Million -1.92 Million -23.3 Million -6.13 Million
Net Income -387.03 Thousand -1.29 Million -2.43 Million -2.41 Million -23.61 Million -6.13 Million
Earnings Per Share Basic -0.01 -0.04 -0.10 -0.15 -1.77 -0.51
Earnings Per Share Diluted -0.01 -0.04 -0.10 -0.15 -1.77 -0.51
Weighted Average Shares Outstanding 32.8 Million 33.24 Million 23.65 Million 16.55 Million 13.37 Million 12.05 Million
Weighted Average Shares Outstanding (Diluted) 32.8 Million 33.24 Million 23.65 Million 16.55 Million 13.37 Million 12.05 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -492.51 Thousand -1.73 Million -923.6 Thousand -1.37 Million -24.23 Million -6.01 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts